ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling
文献类型：期刊论文
| 作者 | Jin Ding; Wen Wen; Daimin Xiang; Peipei Yin; Liu YF(刘艳芳); Chang Liu; Guoping He; Zhuo Cheng; Jianpeng Yin; Chunquan Sheng |
| 刊名 | Oncotarget
 |
| 出版日期 | 2015-12-23 |
| 卷号 | 6期号:13页码:11627 |
| 产权排序 | 3 |
| 通讯作者 | Jin Ding ; Hongyang Wang |
| 语种 | 英语 |
| 源URL | [http://cas-ir.dicp.ac.cn/handle/321008/148024]  |
| 专题 | 大连化学物理研究所_中国科学院大连化学物理研究所 |
| 作者单位 | 大连化学物理研究所 |
| 推荐引用方式 GB/T 7714 | Jin Ding,Wen Wen,Daimin Xiang,et al. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling[J]. Oncotarget,2015,6(13):11627. |
| APA | Jin Ding.,Wen Wen.,Daimin Xiang.,Peipei Yin.,刘艳芳.,...&Hongyang Wang.(2015).ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.Oncotarget,6(13),11627. |
| MLA | Jin Ding,et al."ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling".Oncotarget 6.13(2015):11627. |
入库方式： OAI收割
来源：大连化学物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。